Durability of recaptured response to ozanimod during the True North open-label extension

被引：0
|
作者：
Dignass, A. [1 ]
Regueiro, M. [2 ]
Colombel, J. F. [3 ]
Jain, A. [4 ]
Canavan, J. B. [4 ]
Wu, H. [4 ]
Lawlor, G. [4 ]
Osterman, M. T. [4 ]
Vermeire, S. [5 ]
Rubin, D. T. [6 ]
机构：
[1] Goethe Univ, Med, Agaples Markus Hosp, Frankfurt, Germany
[2] Cleveland Clin Cleveland, Digest Dis & Surg Inst, Cleveland, OH USA
[3] Icahn Sch Med Mt Sinai, Gastroenterol, New York, NY USA
[4] Bristol Myers Squibb, Clin Res, Princeton, NJ USA
[5] Univ Leuven, Chron Dis & Metab, Leuven, Belgium
[6] Univ Chicago, Gastroenterol, Chicago, IL USA
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P687
引用
收藏
页码：817 / 818
页数：2
相关论文
共 50 条
  • [31] Safety of Long-Term Ozanimod Treatment Up to 5 Years in Patients With Moderately to Severely Active Ulcerative Colitis: An Interim Analysis of the True North Open-Label Extension
    Abraham, Bincy P.
    Longman, Randy
    Katsanos, Konstantinos
    Lee, Scott D.
    Kobayashi, Taku
    Bettenworth, Dominik
    Korman, Louis
    Mehra, Dimpy
    Santiago, Norma Ruiz
    Petersen, Annkatrin
    Desai, Manik
    Wu, Hsiuanlin
    Wang, Dong
    Osterman, Mark T.
    Jain, Anjali
    Torres, Joana
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1063 - S1063
  • [32] Humoral immune responses to SARS-CoV-2 vaccines in an ozanimod open-label extension study
    Caldera, F.
    Maddux, R.
    Ungaro, R.
    Kaur, A.
    Brown, E.
    Hu, S.
    Sheffield, J. K.
    Silva, D.
    Harris, S.
    Cree, B. A. C.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 643 - 644
  • [33] Safety patterns with ozanimod in phase 3 and open-label extension trials in patients with relapsing multiple sclerosis
    Selmaj, K. W.
    Ziemssen, T.
    Comi, G.
    Hartung, H. P.
    Singal, M.
    Thorpe, A.
    Riolo, J. V.
    Cheng, C. Y.
    Sheffield, J. K.
    Krakovich, A.
    Vermersch, P.
    Cree, B. A. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 324 - 324
  • [34] Humoral Immune Responses to SARS-CoV-2 Vaccines in an Ozanimod Open-Label Extension Study
    Caldera, Freddy
    Maddux, Rachel
    Ungaro, Ryan
    Kaur, Amandeep
    Brown, Elizabeth
    Hu, Sarah
    Sheffield, James K.
    Silva, Diego
    Harris, Sarah
    Cree, Bruce A. C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S527 - S528
  • [35] Achievement and maintenance of endoscopic, histologic, and combined outcomes after extended induction in Week 10 nonresponders of ozanimod: 2-year interim analysis of the True North open-label extension study
    Vermeire, S.
    Colombel, J. F.
    Rubin, D. T.
    Ghosh, S.
    Jain, A.
    Lawlor, G.
    Osterman, M. T.
    Wu, H.
    Canavan, J. B.
    Chiorean, M. V.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 844 - 845
  • [36] ACHIEVEMENT AND MAINTENANCE OF ENDOSCOPIC, HISTOLOGIC, AND COMBINED OUTCOMES AFTER EXTENDED INDUCTION IN WEEK 10 NONRESPONDERS OF OZANIMOD: 2-YEAR INTERIM ANALYSIS OF THE TRUE NORTH OPEN-LABEL EXTENSION STUDY
    Chiorean, Michael V.
    Colombel, Jean Frederic
    Rubin, David T.
    Ghosh, Subrata
    Jain, Anjali
    Lawlor, Garrett
    Osterman, Mark T.
    Wu, Hsiuanlin
    Canavan, James B.
    Vermeire, Severine
    GASTROENTEROLOGY, 2023, 164 (06) : S1106 - S1107
  • [37] SAFETY OF LONG-TERM OZANIMOD TREATMENT FOR UP TO 4 YEARS BY AGE GROUP IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: AN INTERIM ANALYSIS OF THE TRUE NORTH OPEN-LABEL EXTENSION
    Siegel, Corey A.
    Rubin, David T.
    Long, Millie D.
    Danese, Silvio
    Cross, Raymond K.
    Armuzzi, Alessandro
    Dignass, Axel
    Kobayashi, Taku
    Faye, Adam S.
    Lama, Sonie
    Charles, Lorna
    Cetin, Volkan
    Petersen, AnnKatrin
    Wu, Hsiuanlin
    Wang, Dong
    Jain, Anjali
    Sabino, Joao
    GASTROENTEROLOGY, 2024, 166 (05) : S805 - S806
  • [38] Absolute Lymphocyte Count Around Infections During Phase 3 and Open-Label Extension Trials of Ozanimod in Participants With Relapsing Multiple Sclerosis
    Hartung, Hans-Peter
    Steinman, Lawrence
    Bar-Or, Amit
    Sheffield, James
    Harris, Sarah
    Riolo, Jon
    Cheng, Chun-Yen
    Reardon, Jennifer
    Thorpe, Andrew
    Cree, Bruce
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 354 - 354
  • [39] COVID-19 infections and vaccinations among patients receiving ozanimod in the daybreak open-label extension trial
    Cree, B. A.
    Selmaj, K. W.
    Steinman, L.
    Comi, G.
    Bar-Or, A.
    Arnold, D. L.
    Hartung, H. -P.
    Montalban, X.
    Havrdova, K.
    Desai, H.
    Sheffield, J. K.
    Minton, N.
    Cheng, C. -Y.
    Silva, D.
    Kappos, L.
    Cohen, J. A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 401 - 402
  • [40] Open-label extension studies and misinformation
    Schneider, Lon S.
    ARCHIVES OF NEUROLOGY, 2006, 63 (07) : 1036 - 1036
12345